Skip to main content
. Author manuscript; available in PMC: 2006 Feb 8.
Published in final edited form as: Psychopharmacology (Berl). 2005 Oct 15;181(1):145–152. doi: 10.1007/s00213-005-2230-6

Figure 3.

Figure 3.

Aß plaque deposition in Tg(+) mice treated with physostigmine or donepezil (n= 5-7 per drug group). The effects of drug condition on the total number of Aß-amyloid plaques (panel a) and on the percentage of cortex and hippocampus occupied by Aß-immunoreactive plaques (panel b) were not significant.